Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018 2019

Details for Mechanism ID: 17460
Country/Region: Eswatini
Year: 2016
Main Partner: University Research Corporation, LLC
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: HHS/CDC
Total Funding: $3,028,714 Additional Pipeline Funding: $465,983

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $31,236
Care: TB/HIV (HVTB) $358,578
Testing: HIV Testing and Counseling (HVCT) $301,260
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $156,375
Treatment: Adult Treatment (HTXS) $2,028,588
Treatment: Pediatric Treatment (PDTX) $152,677
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV Age/Sex: <10 Female 2017 4
GEND_GBV Age/Sex: <10 Female 2017 20
GEND_GBV Age/Sex: <10 Male 2017 4
GEND_GBV Age/Sex: <10 Male 2017 20
GEND_GBV Age/Sex: 10-14 Female 2017 6
GEND_GBV Age/Sex: 10-14 Female 2017 28
GEND_GBV Age/Sex: 10-14 Male 2017 6
GEND_GBV Age/Sex: 10-14 Male 2017 28
GEND_GBV Age/Sex: 15-19 Female 2017 6
GEND_GBV Age/Sex: 15-19 Female 2017 28
GEND_GBV Age/Sex: 15-19 Male 2017 6
GEND_GBV Age/Sex: 15-19 male 2017 28
GEND_GBV Age/Sex: 20-24 Female 2017 6
GEND_GBV Age/Sex: 20-24 Female 2017 27
GEND_GBV Age/Sex: 20-24 Male 2017 5
GEND_GBV Age/Sex: 20-24 Male 2017 27
GEND_GBV Age/Sex: 25-49 Female 2017 20
GEND_GBV Age/Sex: 25-49 Female 2017 92
GEND_GBV Age/Sex: 25-49 Male 2017 25
GEND_GBV Age/Sex: 25-49 Male 2017 129
GEND_GBV Age/Sex: 50+ Female 2017 5
GEND_GBV Age/Sex: 50+ Female 2017 26
GEND_GBV Age/Sex: 50+ Male 2017 4
GEND_GBV Age/Sex: 50+ Male 2017 20
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 14
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 71
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 32
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 152
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 65
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 321
GEND_GBV Number of people receiving post-GBV care 2017 97
GEND_GBV Number of people receiving post-GBV care 2017 473
GEND_GBV Sum of Age/Sex Disaggregates 2017 20
GEND_GBV Sum of Age/Sex Disaggregates 2017 96
HTS_TST Age/sex: <1 2017 72
HTS_TST Age/sex: <1 2017 775
HTS_TST Age/sex: 1-9 2017 184
HTS_TST Age/sex: 1-9 2017 1,970
HTS_TST Age/sex: 10-14 Female 2017 20
HTS_TST Age/sex: 10-14 Female 2017 235
HTS_TST Age/sex: 10-14 Male 2017 21
HTS_TST Age/sex: 10-14 Male 2017 226
HTS_TST Age/sex: 15-19 Female 2017 221
HTS_TST Age/sex: 15-19 Female 2017 2,352
HTS_TST Age/sex: 15-19 Male 2017 224
HTS_TST Age/sex: 15-19 Male 2017 2,358
HTS_TST Age/sex: 20-24 Female 2017 425
HTS_TST Age/sex: 20-24 Female 2017 4,536
HTS_TST Age/sex: 20-24 Male 2017 462
HTS_TST Age/sex: 20-24 Male 2017 4,539
HTS_TST Age/sex: 25-49 Female 2017 860
HTS_TST Age/sex: 25-49 Female 2017 9,117
HTS_TST Age/sex: 25-49 Male 2017 932
HTS_TST Age/sex: 25-49 Male 2017 9,154
HTS_TST Age/sex: 50+ Female 2017 188
HTS_TST Age/sex: 50+ Female 2017 2,018
HTS_TST Age/sex: 50+ Male 2017 216
HTS_TST Age/sex: 50+ Male 2017 2,022
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 153
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 1,558
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 145
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 1,550
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 1,692
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 18,110
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 1,835
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 18,084
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 3,825
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 39,302
HTS_TST Service Delivery Point (Facility): Index testing 2017 59
HTS_TST Service Delivery Point (Facility): Inpatient 2017 1,097
HTS_TST Service Delivery Point (Facility): Other PITC 2017 10
HTS_TST Service Delivery Point (Facility): Other PITC 2017 105
HTS_TST Service Delivery Point (Facility): Outpatient 2017 3,001
HTS_TST Service Delivery Point (Facility): Outpatient 2017 29,754
HTS_TST Service Delivery Point (Facility): Pediatric 2017 167
HTS_TST Service Delivery Point (Facility): Pediatric 2017 1,719
HTS_TST Service Delivery Point (Facility): PMTCT 2017 383
HTS_TST Service Delivery Point (Facility): PMTCT 2017 3,880
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 39
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 376
HTS_TST Service Delivery Point (Facility): VCT 2017 225
HTS_TST Service Delivery Point (Facility): VCT 2017 2,312
HTS_TST Sum of Age/Sex disaggregates 2017 3,569
HTS_TST Sum of Age/Sex disaggregates 2017 36,557
HTS_TST Sum of Aggregated Age/Sex <15 2017 298
HTS_TST Sum of Aggregated Age/Sex <15 2017 3,108
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 3,527
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 36,194
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 3,825
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 39,302
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 1
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 33
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 1
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 34
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 21
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 245
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 21
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 240
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 42
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 463
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 51
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 463
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 85
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 911
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 97
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 945
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 19
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 202
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 26
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 208
HTS_TST_POS Test Result by Age: Positive: <1 2017 7
HTS_TST_POS Test Result by Age: Positive: <1 2017 74
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 19
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 187
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 17
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 170
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 11
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 158
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 166
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 1,818
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 196
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 1,859
PMTCT_ART Already on ART at beginning of current pregnancy 2017 83
PMTCT_ART Already on ART at beginning of current pregnancy 2017 931
PMTCT_ART New on ART 2017 71
PMTCT_ART New on ART 2017 793
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 416
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 5,335
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 138
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 1,550
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 16
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 173
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 3
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 29
PMTCT_EID Sum of Infant Age disaggregates 2017 154
PMTCT_EID Sum of Infant Age disaggregates 2017 1,723
PMTCT_STAT By Age (DREAMS SNUs ONLY): <15 2017 13
PMTCT_STAT By Age (DREAMS SNUs ONLY): <15 2017 159
PMTCT_STAT By Age (DREAMS SNUs ONLY): 15-19 2017 51
PMTCT_STAT By Age (DREAMS SNUs ONLY): 15-19 2017 650
PMTCT_STAT By Age (DREAMS SNUs ONLY): 20-24 2017 100
PMTCT_STAT By Age (DREAMS SNUs ONLY): 20-24 2017 1,314
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 243
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 3,099
PMTCT_STAT By Age (DREAMS SNUs ONLY): 50+ 2017 9
PMTCT_STAT By Age (DREAMS SNUs ONLY): 50+ 2017 113
PMTCT_STAT By: Known positives at entry 2017 100
PMTCT_STAT By: Known positives at entry 2017 1,185
PMTCT_STAT By: Number of new positives identified 2017 54
PMTCT_STAT By: Number of new positives identified 2017 638
PMTCT_STAT Number of new ANC and L&D clients 2017 438
PMTCT_STAT Number of new ANC and L&D clients 2017 5,616
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 416
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 5,335
PMTCT_STAT Required only for DREAMS countries - By known positives: <15 2017 3
PMTCT_STAT Required only for DREAMS countries - By known positives: 15-19 2017 13
PMTCT_STAT Required only for DREAMS countries - By known positives: 20-24 2017 25
PMTCT_STAT Required only for DREAMS countries - By known positives: 25-49 2017 58
PMTCT_STAT Required only for DREAMS countries - By known positives: 50+ 2017 2
PMTCT_STAT Required only for DREAMS countries - By new positives: <15 2017 1
PMTCT_STAT Required only for DREAMS countries - By new positives: 15-19 2017 7
PMTCT_STAT Required only for DREAMS countries - By new positives: 20-24 2017 13
PMTCT_STAT Required only for DREAMS countries - By new positives: 25-49 2017 32
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: <15 2017 35
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 15-19 2017 155
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 20-24 2017 296
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 25-49 2017 675
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 50+ 2017 23
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: <15 2017 18
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 15-19 2017 82
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 20-24 2017 160
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 25-49 2017 369
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 50+ 2017 10
PMTCT_STAT Sum of Positives Status disaggregates 2017 154
PMTCT_STAT Sum of Positives Status disaggregates 2017 1,823
PMTCT_STAT_den Required only for DREAMS countries - Denominator: <15 2017 9
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15 2017 179
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15-19 2017 728
PMTCT_STAT_den Required only for DREAMS countries - Denominator: 15-19 2017 53
PMTCT_STAT_den Required only for DREAMS countries - Denominator: 20-24 2017 113
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 20-24 2017 1,422
PMTCT_STAT_den Required only for DREAMS countries - Denominator: 25-49 2017 250
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 25-49 2017 3,147
PMTCT_STAT_den Required only for DREAMS countries - Denominator: 50+ 2017 13
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 50+ 2017 140
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 38
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 9
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 308
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 2
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 37
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 8
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 276
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 20
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 667
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 19
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 659
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 1,780
TB_SCREENDX [Sub-Disagg of Screen Results] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 27
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Other (Not Xpert) 2017 1
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 90
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 27
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 1,692
TB_SCREENDX Screen Result: Screened Positive for TB 2017 1,832
TB_SCREENDX Screen Results: Screened Positive for TB 2017 28
TB_SCREENDX Screened for TB by Age/Sex: <15 Female 2017 24
TB_SCREENDX Screened for TB by Age/Sex: <15 Male 2017 21
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 277
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 17,891
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 246
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 15,860
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 1,563
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 1,388
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 568
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 36,702
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 55
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 11
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 445
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 3
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 51
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 13
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 398
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 28
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 949
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 28
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 949
TX_CURR Age/Sex: <1 2017 21
TX_CURR Age/Sex: <1 2017 1,279
TX_CURR Age/Sex: <1-9 2017 848
TX_CURR Age/Sex: 1-9 2017 14
TX_CURR Age/Sex: 10-14 Female 2017 6
TX_CURR Age/Sex: 10-14 Female 2017 325
TX_CURR Age/Sex: 10-14 Male 2017 7
TX_CURR Age/Sex: 10-14 Male 2017 461
TX_CURR Age/Sex: 15-19 Female 2017 1,388
TX_CURR Age/Sex: 15-19 Female 2017 24
TX_CURR Age/Sex: 15-19 Male 2017 96
TX_CURR Age/Sex: 20-24 Female 2017 81
TX_CURR Age/Sex: 20-24 Female 2017 4,761
TX_CURR Age/Sex: 20-24 Male 2017 9
TX_CURR Age/Sex: 20-24 Male 2017 596
TX_CURR Age/Sex: 25-49 Female 2017 257
TX_CURR Age/Sex: 25-49 Female 2017 14,620
TX_CURR Age/Sex: 25-49 Male 2017 156
TX_CURR Age/Sex: 25-49 Male 2017 8,860
TX_CURR Age/Sex: 50+ Female 2017 31
TX_CURR Age/Sex: 50+ Female 2017 1,821
TX_CURR Age/Sex: 50+ Male 2017 28
TX_CURR Age/Sex: 50+ Male 2017 1,581
TX_CURR Aggregated Age/Sex: <15 Female 2017 1,645
TX_CURR Aggregated Age/Sex: <15 Female 2017 31
TX_CURR Aggregated Age/Sex: <15 Male 2017 1,309
TX_CURR Aggregated Age/Sex: <15 Male 2017 27
TX_CURR Aggregated Age/Sex: 15+ Female 2017 387
TX_CURR Aggregated Age/Sex: 15+ Female 2017 22,561
TX_CURR Aggregated Age/Sex: 15+ Male 2017 11,121
TX_CURR Aggregated Age/Sex: 15+ Male 2017 189
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 36,636
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 634
TX_CURR Sum of age/sex disaggregates 2017 1,484
TX_CURR Sum of Age/Sex disaggregations 2017 24
TX_CURR Sum of Aggregated Age/Sex <15 2017 58
TX_CURR Sum of Aggregated Age/Sex <15 2017 2,954
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 576
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 33,682
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 634
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 36,636
TX_NEW Aggregated Grouping by Age: <1 2017 15
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 23
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 313
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 19
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 251
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 254
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 4,288
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 127
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 2,104
TX_NEW By Age/Sex: <1 2017 243
TX_NEW By Age/Sex: 1-9 2017 10
TX_NEW By Age/Sex: 1-9 2017 163
TX_NEW By Age/Sex: 10-14 Female 2017 4
TX_NEW By Age/Sex: 10-14 Female 2017 62
TX_NEW By Age/Sex: 10-14 Male 2017 4
TX_NEW By Age/Sex: 10-14 Male 2017 89
TX_NEW By Age/Sex: 15-19 Female 2017 14
TX_NEW By Age/Sex: 15-19 Female 2017 267
TX_NEW By Age/Sex: 15-19 Male 2017 20
TX_NEW By Age/Sex: 20-24 Female 2017 51
TX_NEW By Age/Sex: 20-24 Female 2017 894
TX_NEW By Age/Sex: 20-24 Male 2017 6
TX_NEW By Age/Sex: 20-24 Male 2017 115
TX_NEW By Age/Sex: 25-49 Female 2017 162
TX_NEW By Age/Sex: 25-49 Female 2017 2,791
TX_NEW By Age/Sex: 25-49 Male 2017 98
TX_NEW By Age/Sex: 25-49 Male 2017 1,644
TX_NEW By Age/Sex: 50+ Female 2017 33
TX_NEW By Age/Sex: 50+ Female 2017 351
TX_NEW By Age/Sex: 50+ Male 2017 26
TX_NEW By Age/Sex: 50+ Male 2017 317
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 423
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 6,956
TX_NEW Sum of Age/Sex disaggregates 2017 398
TX_NEW Sum of Age/Sex disaggregates 2017 6,550
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 423
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 6,956
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 426
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 33,343
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 310
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 24,342
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 12
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 880
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 10
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 716
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 190
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 14,992
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 98
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 7,754
TX_PVLS Numerator: Indication: Routine 2017 218
TX_PVLS Numerator: Indication: Routine 2017 17,040
TX_PVLS Numerator: Indication: Targeted 2017 92
TX_PVLS Numerator: Indication: Targeted 2017 7,302
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 16
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 1,204
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 12
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 978
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 264
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 20,546
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 134
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 10,615
TX_PVLS_den Denominator: Indication: Routine 2017 297
TX_PVLS_den Denominator: Indication: Routine 2017 23,338
TX_PVLS_den Denominator: Indication: Targeted 2017 129
TX_PVLS_den Denominator: Indication: Targeted 2017 10,005
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 184
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 105
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 43
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 3
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 65
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 198
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 11
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 5
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 688
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 85
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 18
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,155
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 13
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,281
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 263
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 229
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 5
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 562
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 5
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 498
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 18
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,254
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 18
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,993
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 46
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 5,307
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 51
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 5,767
TX_RET_den Age/Sex: <1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 198
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 116
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 3
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 58
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 3
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 78
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 220
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 12
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 6
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 747
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 94
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 20
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,320
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 13
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,389
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 3
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 287
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 248
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 5
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 611
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 5
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 543
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 23
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,445
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 18
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,168
Cross Cutting Budget Categories and Known Amounts Total: $153,367
Motor Vehicles: Purchased $153,367